Clinical trials
Recruiting Fanconi Anemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Masonic Cancer Center, University of Minnesota | 2 |
| National Cancer Institute (NCI) | 2 |
| St. Jude Children's Research Hospital | 2 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Children's Hospital Medical Center, Cincinnati | 1 |
| Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 1 |
| Istituto Giannina Gaslini | 1 |
| Porteus, Matthew, MD | 1 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1 |
| University of Minnesota | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fanconi Anemia | 13 |
| Dyskeratosis Congenita | 6 |
| Anemia, Diamond-Blackfan | 4 |
| Bone Marrow Failure Disorders | 4 |
| Anemia, Aplastic | 3 |
| Congenital Bone Marrow Failure Syndromes | 3 |
| Myelodysplastic Syndromes | 3 |
| Adenomatous Polyposis Coli | 1 |
| Adrenocortical Carcinoma | 1 |
| Anemia, Refractory, with Excess of Blasts | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.